Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health, Inc. (DE:82W)
NYSE:82W
Total Valuation
Hims & Hers Health has a market cap or net worth of €4.92B. The enterprise value is €6.47B.
Market Cap€4.92B
Enterprise Value€6.47B
Share Statistics
Hims & Hers Health has 219,561,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,561,140
Owned by Insiders5.10%
Owned by Institutions12.13%
Financial Efficiency
Hims & Hers Health’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 6.93%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)6.93%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee1.43M
Profits Per Employee78.41K
Employee Count1,637
Asset Turnover1.09
Inventory Turnover8.25
Valuation Ratios
The current PE Ratio of Hims & Hers Health is 56.9. Hims & Hers Health’s PEG ratio is -33.00.
PE Ratio56.9
PS Ratio3.11
PB Ratio13.50
Price to Fair Value13.50
Price to FCF98.76
Price to Operating Cash Flow18.54
PEG Ratio-33.00
Income Statement
In the last 12 months, Hims & Hers Health had revenue of 2.35B and earned 128.37M in profits. Earnings per share was 0.57.
Revenue2.35B
Gross Profit1.39B
Operating Income121.69M
Pretax Income123.92M
Net Income128.37M
EBITDA178.43M
Earnings Per Share (EPS)0.57
Cash Flow
In the last 12 months, operating cash flow was 303.40M and capital expenditures -230.54M, giving a free cash flow of 72.86M billion.
Operating Cash Flow303.40M
Free Cash Flow72.86M
Free Cash Flow per Share0.33
Dividends & Yields
Hims & Hers Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.62
52-Week Price Change-32.29%
50-Day Moving Average20.33
200-Day Moving Average35.94
Relative Strength Index (RSI)65.05
Average Volume (3m)3.90K
Important Dates
Hims & Hers Health upcoming earnings date is May 11, 2026, TBA (Confirmed).
Last Earnings DateFeb 23, 2026
Next Earnings DateMay 11, 2026
Ex-Dividend Date―
Financial Position
Hims & Hers Health as a current ratio of 1.90, with Debt / Equity ratio of 233.63%
Current Ratio1.90
Quick Ratio1.61
Debt to Market Cap0.15
Net Debt to EBITDA5.80
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hims & Hers Health has paid -4.44M in taxes.
Income Tax-4.44M
Effective Tax Rate-0.04
Enterprise Valuation
Hims & Hers Health EV to EBITDA ratio is 46.74, with an EV/FCF ratio of 112.76.
EV to Sales3.55
EV to EBITDA46.74
EV to Free Cash Flow112.76
EV to Operating Cash Flow27.80
Balance Sheet
Hims & Hers Health has €577.49M in cash and marketable securities with €1.26B in debt, giving a net cash position of -€686.26M billion.
Cash & Marketable Securities€577.49M
Total Debt€1.26B
Net Cash-€686.26M
Net Cash Per Share-€3.13
Tangible Book Value Per Share€0.30
Margins
Gross margin is 69.65%, with operating margin of 5.18%, and net profit margin of 5.47%.
Gross Margin69.65%
Operating Margin5.18%
Pretax Margin5.28%
Net Profit Margin5.47%
EBITDA Margin7.60%
EBIT Margin5.28%
Analyst Forecast
The average price target for Hims & Hers Health is €22.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€22.08
Price Target Upside1.52% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast―
EPS Growth Forecast―